Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

OBJECTIVE: The obesity epidemic is a public health concern, warranting further research into pharmacological treatments for weight management (WM) as an adjunct to lifestyle interventions. The Semaglutide Treatment Effect in People with obesity (STEP) program aims to investigate the effect of semagl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kushner, Robert F., Calanna, Salvatore, Davies, Melanie, Dicker, Dror, Garvey, W. Timothy, Goldman, Bryan, Lingvay, Ildiko, Thomsen, Mette, Wadden, Thomas A., Wharton, Sean, Wilding, John P.H., Rubino, Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318657/
https://www.ncbi.nlm.nih.gov/pubmed/32441473
http://dx.doi.org/10.1002/oby.22794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318657/
https://www.ncbi.nlm.nih.gov/pubmed/32441473
http://dx.doi.org/10.1002/oby.22794

Ejemplares similares